31 Mar 2019
Assets2.15
Total Income3.25
EBITDA0.02
Profit After Tax0.01
NET Worth0.02
Reserves and Surplus0.01
Total Borrowing0.00
Open 17th Mar 2022 · Close 22nd Mar 2022 · Listing 30th Mar 2022
Evoq Remedies is a SME IPO with an issue size of ₹9.72 crore, proposed for listing on BSE SME. The offer opens on 17th Mar 2022 and closes on 22nd Mar 2022. The issue structure includes a fresh issue of ₹9.23 crore.
| Investor | Lots | Shares | Amount |
|---|---|---|---|
| Minimum Bid | 1 | 4000 | — |
| Object | Amount |
|---|---|
| To Meet Incremental Working Capital Requirements | ₹6.44 Cr |
| General Corporate Purpose | ₹2.33 Cr |
| KPI |
|---|
| RoNW |
| Expense | Amount |
|---|---|
| Lead Manger Fees including Underwriting Commission | ₹0.18 Cr |
| Fees for Advisor to the Issue | ₹0.03 Cr |
| Fees Payable to Registrar to the Issue | ₹0.01 Cr |
| Fees Payable Advertising, Marketing Expenses and Printing Expenses | ₹0.64 Cr |
| Fees Payable to Regulators including Stock Exchanges and other Intermediaries | ₹0.04 Cr |
| Fees payable to Peer Review Auditor | ₹0.01 Cr |
| Fees Payable to Market Maker (for Two Years) | ₹0.04 Cr |
| Escrow Bank Fees | ₹0.01 Cr |